About Jay Shepard
Form D filings for Cessation Therapeutics from 2022 to 2024 list Jay Shepard as director.
Jay Shepard first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Jay Shepard in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jay Shepard works with at each company, as listed on that company's latest Form D.
Cessation Therapeutics, Inc. · Form D, Apr 3, 2024